Enhabit, Inc. (NYSE:EHAB – Get Rating) gapped down before the market opened on Friday after Citigroup lowered their price target on the stock from $18.00 to $15.00. The stock had previously closed at $12.80, but opened at $12.52. Enhabit shares last traded at $12.12, with a volume of 66,543 shares.
Other equities research analysts have also issued research reports about the company. Stifel Nicolaus lifted their price objective on Enhabit from $17.00 to $18.00 in a report on Wednesday, February 15th. The Goldman Sachs Group started coverage on Enhabit in a report on Thursday, March 16th. They issued a “neutral” rating and a $15.00 price objective on the stock. Finally, Credit Suisse Group reissued a “neutral” rating and set a $15.00 price target on shares of Enhabit in a research note on Thursday, February 16th. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $16.13.
Institutional Inflows and Outflows
Institutional investors have recently bought and sold shares of the business. PNC Financial Services Group Inc. increased its holdings in shares of Enhabit by 5.3% during the 4th quarter. PNC Financial Services Group Inc. now owns 16,777 shares of the company’s stock worth $221,000 after buying an additional 847 shares during the last quarter. Cerity Partners LLC acquired a new stake in shares of Enhabit during the 1st quarter worth $459,000. IFP Advisors Inc acquired a new stake in shares of Enhabit during the 3rd quarter worth $39,000. Signaturefd LLC increased its holdings in shares of Enhabit by 99.9% during the 1st quarter. Signaturefd LLC now owns 1,875 shares of the company’s stock worth $26,000 after buying an additional 937 shares during the last quarter. Finally, Bessemer Group Inc. purchased a new stake in Enhabit during the 3rd quarter worth $26,000. 95.55% of the stock is currently owned by institutional investors and hedge funds.
Enhabit Price Performance
The business’s 50-day moving average is $13.31 and its two-hundred day moving average is $13.70. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.73.
Enhabit (NYSE:EHAB – Get Rating) last announced its quarterly earnings results on Tuesday, February 14th. The company reported $0.32 earnings per share for the quarter, topping analysts’ consensus estimates of $0.25 by $0.07. Enhabit had a net margin of 5.77% and a return on equity of 7.60%. The firm had revenue of $275.10 million during the quarter, compared to analysts’ expectations of $268.15 million. As a group, sell-side analysts expect that Enhabit, Inc. will post 0.71 earnings per share for the current year.
Enhabit Company Profile
Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer’s disease, low vision, spinal stenosis, Parkinson’s disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.